Return to Article Details
FORMULATION DEVELOPMENT AND STATISTICAL OPTIMIZATION OF A BILAYER TABLET OF BOSENTAN MONOHYDRATE AND SILDENAFIL CITRATE IN MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION